New Therapeutic Options for Migraine

Curr Pharm Des. 2023;29(25):1964-1966. doi: 10.2174/1381612829666230821092238.

Authors

Claudio Tana¹, Francesco Cipollone², Maria Adele Giamberardino³

Affiliations

¹ Center of Excellence on Headache and Geriatrics Clinic, SS Annunziata Hospital of Chieti, Chieti, Italy.
² Department of Medicine and Science of Aging, Medical Clinic, SS. Annunziata Hospital of Chieti, "G. D'Annunzio" University of Chieti, Chieti, Italy.
³ Department of Medicine and Science of Aging and CAST, G. D'Annunzio University of Chieti, Chieti, Italy.

PMID: 37605392
DOI: 10.2174/1381612829666230821092238

No abstract available

Keywords: Migraine; atogepant; calcitonin gene related peptide (CGRP); erenumab; guidelines; lasmiditan; trigeminal system.

Publication types

Editorial

MeSH terms

Calcitonin Gene-Related Peptide / therapeutic use
Humans
Migraine Disorders* / drug therapy

Substances

Calcitonin Gene-Related Peptide